Aleksey N. Krylov

Aleksey N. Krylov has over fifteen years of experience in the finance and healthcare industries. Aleksey is currently the President & CFO at Biobohemia and has held previous positions at Heliosonix, BIOBOHEMIA, Inc., DIH Technologies Co., reVision Therapeutics, Inc., and Sellas Life Sciences. At BIOBOHEMIA, Aleksey partnered with the CEO and founding team on capital raising and business development work. Aleksey was also responsible for the financial operations of this Nasdaq-listed biotech company. Throughout their career, Aleksey has demonstrated their ability to successfully partner with CEOs and C-level executives to deliver on critical milestones. Aleksey is a strategic thinker with a track record of success in both public and private companies.

Aleksey N. Krylov graduated from The Hill School, a prep school, and then went on to Babson College where they earned their BS in finance/investment banking. Aleksey then attended Columbia Business School where they earned their MBA in finance/investment banking.

Aleksey N. Krylov reports to Petr Lokhov, Co-Founder, CEO, Chief Scientific Officer. They work with Elena Balashova - Senior Scientist, Steven Lichtenberg - Chief Operating Officer.